Pharma Boehringer Ingelheim
Progressive Pulmonary Fibrosis: Myths and Facts

17.30 – Welcome and introductions, Marlies Wijsenbeek (The Netherlands)
17.35 – It is important for patients with ILD to receive an accurate differential diagnosis? Myth or fact?, Maria Molina Molina (Spain)
17.50 – There are multiple drugs approved to treat PF ILD – Myth or fact?, Marlies Wijsenbeek (The Netherlands)
18.05 – The INBUILD trial was a collection of trials in individual diseases – Myth or fact?, Luca Richieldi (Italy)
18.20 – Q&A session, Faculty
Chairs: Marlies Wijsenbeek (The Netherlands)